Artificial wombs could someday save babies born very prematurely. Even though the experimental technology is still in animal tests, there are mounting questions about its eventual use with humans.
Scientific advances in immunotherapy and new targeted therapies have increased survival rates. But screening among former and current smokers still needs to improve to save more lives.
Surgeons at Massachusetts General Hospital said they transplanted a genetically edited pig kidney into a living human for the first time. The 62-year-old recipient has end-stage kidney disease.
The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic.
Scientists are optimistic that gene-edited animals could provide a new source of organs for transplantation. Pig organs modified to minimize rejection are now being tested in humans.
After seven years of research, the findings shed light on the long-neglected illness. Scientists say the results could lead to future trials for potential treatments.
A doctor argues that the current focus on fighting obesity with drugs like Ozempic ignores the bigger picture: We need a medical system and society that support healthy life habits.
Long COVID patients can experience severe energy crashes after physical exertion. New research provides clear evidence that there's a biological basis for the symptoms.
A new generation of blood tests can help doctors diagnose Alzheimer's without a brain scan or spinal tap. But only a few perform as well as traditional tests.
A new approach to schizophrenia involves managing early psychosis symptoms and keeping young people in school or jobs. The treatment is effective, but private insurance plans don't usually cover it.
Flovent — a common asthma inhaler — will be discontinued in 2024. There will be a generic version available, but the change could make it hard for some patients to get their medication.
To treat amblyopia, or lazy eye, doctors typically prescribe a patch to cover the stronger eye and make the brain learn to work with the weaker one. Virtual reality offers a new approach.
In early December, the Food and Drug Administration approved a gene-editing treatment for sickle cell disease, the first for any illness. One patient helped pave the way.